These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 27168057)

  • 1. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
    Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
    Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
    Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
    Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
    Front Immunol; 2018; 9():669. PubMed ID: 29740427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Zhao Y; Zheng X; Li M; Zhao J; Wang X; Zhu H
    Int Immunopharmacol; 2023 Feb; 115():109620. PubMed ID: 36577155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model.
    Lee ES; Lim JY; Im KI; Kim N; Nam YS; Jeon YW; Cho SG
    PLoS One; 2015; 10(9):e0138846. PubMed ID: 26393514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of bone marrow mesenchymal stem cells overexpressing heme oxygenase-1: Protective effects on acute rejection following reduced-size liver transplantation in a rat model.
    Shen ZY; Wu B; Liu T; Yang Y; Yin ML; Zheng WP; Zhang BY; Song HL
    Cell Immunol; 2017 Mar; 313():10-24. PubMed ID: 28069109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
    Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
    Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme oxygenase-1 ameliorates dextran sulfate sodium-induced acute murine colitis by regulating Th17/Treg cell balance.
    Zhang L; Zhang Y; Zhong W; Di C; Lin X; Xia Z
    J Biol Chem; 2014 Sep; 289(39):26847-26858. PubMed ID: 25112868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SIRT1 deficiency in CD4+T cells induces acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Zhang Y; Yang J; Zhang G; Peng J; Chen X; Chen F; Xu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):697-703. PubMed ID: 30124203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Heme Oxygenase-1 as a Novel Predictor of Hematopoietic Stem Cell Transplantation Outcomes in Acute Leukemia.
    Lu Y; Wu D; Wang J; Li Y; Ma D; Chai X; Kang Q
    Cell Physiol Biochem; 2016; 39(4):1495-502. PubMed ID: 27606430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
    Yao Y; Wang L; Zhou J; Zhang X
    J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
    Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
    Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
    Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
    Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.
    Park MJ; Lee SH; Lee SH; Kim EK; Lee EJ; Moon YM; La Cho M
    J Transl Med; 2016 Jul; 14(1):206. PubMed ID: 27391226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.